Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 6Colonic Neoplasms 2Pancreatic Neoplasms 1Ovarian Neoplasms 1Heartburn 1Gastroesophageal Reflux 1Esophageal Neoplasms 1Colorectal Cancer Screening 1COVID-19 1Breast Neoplasms 1Breast Cancer Screening 1Behavior 1Barrett Esophagus 1

Interventions

Fluorouracil 219Leucovorin 202Oxaliplatin 192Irinotecan 150Bevacizumab 110Capecitabine 94Cetuximab 90Folfox protocol 54Chemotherapy, Adjuvant 36Panitumumab 30Colonoscopy 30pembrolizumab 23Drug Therapy 23Nivolumab 22Magnetic Resonance Spectroscopy 22Gemcitabine 21Blood Specimen Collection 20Radiotherapy 19Floxuridine 19Biopsy 19Neoadjuvant Therapy 18Laparoscopy 18IFL protocol 18Early Intervention, Educational 18Celecoxib 18Surveys and Questionnaires 17Surgical Procedures, Operative 16Immunohistochemistry 16Exercise 16trifluridine tipiracil drug combination 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Colonic Neoplasms × Decision Support Techniques × Gastrointestinal × Clear all
NCT04548531 2023-02-22

Engaging Patients in Colon Cancer Screening Decisions During COVID-19

Massachusetts General Hospital

Phase NA Completed
800 enrolled 13 charts
Gastrointestinal

COVID-19, Colonic Neoplasms

NCT02377232 2017-06-26

CRCSreening

University of Colorado, Denver

Phase NA Completed
424 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡